Geode Capital Management LLC Has $3.20 Million Stock Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Geode Capital Management LLC increased its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 10.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 135,959 shares of the company’s stock after acquiring an additional 12,964 shares during the period. Geode Capital Management LLC owned about 1.87% of Semler Scientific worth $3,202,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the stock. Newbridge Financial Services Group Inc. acquired a new stake in Semler Scientific in the second quarter worth about $34,000. Quest Partners LLC bought a new stake in shares of Semler Scientific in the 2nd quarter valued at about $59,000. Meeder Asset Management Inc. bought a new position in shares of Semler Scientific in the second quarter valued at about $67,000. US Bancorp DE boosted its stake in Semler Scientific by 60.8% in the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after purchasing an additional 1,158 shares during the period. Finally, Rhumbline Advisers increased its holdings in shares of Semler Scientific by 27.1% during the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after purchasing an additional 1,320 shares during the period. 49.37% of the stock is currently owned by institutional investors and hedge funds.

Semler Scientific Price Performance

Shares of NASDAQ:SMLR opened at $58.94 on Tuesday. The stock has a market capitalization of $546.20 million, a price-to-earnings ratio of 28.75 and a beta of 1.18. The company’s 50 day simple moving average is $55.45 and its 200 day simple moving average is $38.08. Semler Scientific, Inc. has a 1 year low of $20.88 and a 1 year high of $81.56.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The company had revenue of $13.51 million for the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.